PF-51481 |
FUSIMED Ungüento Tópico |
2024-07-25 |
|
Med Pharma |
Guatemala
|
Med Pharma |
Servicio De Comercio Internacional |
Selectpharma |
La Botica |
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-51493 |
PANTOPRAZOL Lancasco 40 mg Cápsulas con gránulos entéricos |
2024-10-28 |
|
Lancasco S.A |
Guatemala
|
Lancasco S.A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-51514 |
KOLD GRIP 500 mg Polvo para solución oral |
2020-06-19 |
|
Med Pharma |
Guatemala
|
Med Pharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-51535 |
IBUPROFENO + METACARBAMOL Selectpharma 300-250 mg Tabletas recubiertas |
2025-02-26 |
|
Selectpharma |
Guatemala
|
Med Pharma |
Servicio De Comercio Internacional |
Selectpharma |
La Botica |
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-51536 |
FUSIMED B Ungüento tópico |
2024-07-26 |
|
Med Pharma |
Guatemala
|
Bodega Farmacéutica S.A. |
Med Pharma |
Servicio De Comercio Internacional |
Selectpharma |
La Botica |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-51537 |
IBUPROFENO + METOCARBAMOL Lamfer 300-250 mg Tableta recubierta |
2024-10-08 |
|
Laboratorios Lamfer |
Guatemala
|
Laboratorios Lamfer |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-51540 |
VENLAFAXINA XR Med Pharma 150 mg Cápsulas con gránulos de liberación prolongada |
2024-10-28 |
|
Med Pharma |
Guatemala
|
Med Pharma |
Servicio De Comercio Internacional |
Selectpharma |
La Botica |
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-51545 |
FEXALAR 30 mg /5 mL Suspensión oral |
2024-12-20 |
|
Med Pharma |
Guatemala
|
Bodega Farmacéutica S.A. |
Med Pharma |
Servicio De Comercio Internacional |
Selectpharma |
La Botica |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-51546 |
ALERMINE CORT 5mg+0.25mg/5 mL Solución oral |
2024-11-13 |
|
Selectpharma |
Guatemala
|
Med Pharma |
Servicio De Comercio Internacional |
Selectpharma |
La Botica |
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-51548 |
CLAVCIL Bid Polvo para suspensión oral |
2024-11-08 |
|
Genpharm de Guatemala |
Guatemala
|
Genpharm de Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|